CancerGene Connect (Ommdom)

CancerGene Connect (Ommdom)

Leaders in hereditary cancer risk assessment . Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€1—2m (Dealroom.co estimates Oct 2016.)
Dallas Texas (HQ)
  • Edit
DateInvestorsAmountRound

$690k

Seed
N/A

$300k

Seed

N/A

Acquisition
Total Funding€900k

Recent News about CancerGene Connect (Ommdom)

Edit
More about CancerGene Connect (Ommdom)info icon
Edit

CaGene operates in the healthcare technology sector, specializing in genetic assessment platforms designed to streamline patient data collection and risk analysis. The company primarily serves healthcare providers, including hospitals and clinics, by offering tools that enhance the efficiency and accuracy of patient assessments. CaGene's core product features a Mobile Questionnaire that allows patients to share their information in real-time, providing healthcare providers with a clear view of patient progress. Additionally, the Provider Portal simplifies the organization and access to patient data, offering functionalities such as pedigree creation, viewing, and editing, as well as control over assessment models and reports. The business model is based on a subscription service, where healthcare providers pay for access to the platform and its features. Revenue is generated through these subscriptions, as well as potential add-on services and customizations. The market for CaGene's services includes healthcare institutions focused on genetic risk assessments and personalized patient care.

Keywords: genetic assessment, healthcare technology, patient data, risk analysis, mobile questionnaire, provider portal, pedigree creation, real-time data, subscription service, personalized care.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.